Medical News Observer

Key Points

• Biological clocks, categorized as phenotypic or epigenetic, offer precise tools for measuring aging and predicting health outcomes.
• Epigenetic clocks excel in estimating chronological age through DNA methylation, while phenotypic clocks better predict mortality using clinical biomarkers.
• These innovative tools are transforming aging research, preventive healthcare, and personalized medicine with advanced machine-learning techniques.

Introduction

Advancements in medical technology are transforming how we understand and manage aging. Biological clocks that measure aging are gaining traction for their potential to predict mortality, detect age-related diseases, and personalize healthcare interventions. By combining clinical biomarkers or cellular data with cutting-edge analytics, these clocks offer insights that go far beyond traditional chronological age measurements, opening new frontiers in preventive healthcare. A recent review published in Aging, titled “A systematic review of phenotypic and epigenetic clocks used for aging and mortality quantification in humans,” highlights the transformative potential of these tools in medical practice.

How Biological Clocks Work

Biological clocks fall into two main categories: phenotypic clocks and epigenetic clocks. Phenotypic clocks rely on easily measurable clinical biomarkers such as blood pressure, cholesterol, and glucose levels, which provide insights into an individual’s physiological age. These clocks are valued for their affordability, simplicity, and ability to predict health outcomes and mortality more effectively than chronological age. On the other hand, epigenetic clocks analyze DNA methylation patterns—chemical modifications that occur in cells over time. 

Insights from the Review

Brandon Warner and colleagues analyzed 33 biological clocks developed over the last decade. Published in Aging, the study categorizes these clocks, outlines their predictive performance, and highlights the methodologies used, including advanced statistical and machine learning techniques. The review underscores that while epigenetic clocks excel in estimating chronological age, phenotypic clocks provide superior mortality and health outcome predictions, making them invaluable for routine clinical use.

Regulatory Approvals and Development

Although biological clocks are not yet widely regulated as standalone medical devices, their integration into healthcare is expanding. Researchers emphasize the need for further studies to make epigenetic clocks more cost-effective and widely accessible. Meanwhile, due to their reliance on standard clinical data, phenotypic clocks are already finding practical applications in routine healthcare.

Potential Applications in Medicine

Biological clocks are set to transform medical practice in several ways:

• Early Disease Detection: By identifying deviations from expected biological age, these tools can flag potential health risks early.
• Personalized Interventions: Tailored treatments and lifestyle recommendations can be designed to slow aging and prevent age-related diseases.
• Preventive Healthcare: Monitoring biological age can encourage healthier behaviors and help track the effectiveness of interventions.

Impact on Patient Care

Biological clocks promise to shift the focus from reactive treatment to proactive health management. Their ability to quantify aging and predict mortality could redefine how clinicians assess risk, plan interventions, and engage patients in their healthcare journeys. As research advances, these tools could become integral to personalized medicine, improving health outcomes and extending quality of life.

Conclusion

This systematic review, published in Aging (DOI: 10.18632/aging.206098), underscores the transformative potential of biological clocks in aging research and healthcare. By leveraging cutting-edge analytics and clinical biomarkers, these tools offer unprecedented insights into the aging process and its health implications. As they evolve, biological clocks are poised to play a central role in shaping the future of preventive healthcare and personalized medicine.

Reference

Warner, Brandon, Edward Ratner, Anirban Datta, and Amaury Lendasse. 2024. “A Systematic Review of Phenotypic and Epigenetic Clocks Used for Aging and Mortality Quantification in Humans.” Aging 16 (17): 12414–27. https://doi.org/10.18632/aging.206098.